Back to Stakeholders

CHU de Quebec-Universite Laval

Canada
1 Trial

CHU de Québec–Université Laval is Quebec City's largest university hospital network, affiliated with Université Laval and serving as a major clinical research hub. It hosts the P3A Study Group led by Dr. Michel Dorval (Oncology Division), conducting a psilocybin-assisted psychotherapy trial for existential distress in patients with advanced cancer.

Quick Facts

Type
Other
HQ
Canada
Website
Visit

Collaborated Trials

1